Cheetah Medical has reported that the FDA has approved for marketing the Reliant, a highly accurate, portable cardiac output monitor which provides a noninvasive window to cardiac and hemodynamic function.
Subscribe to our email newsletter
The Reliant monitor is powered by Cheetah’s unique, patented Bioreactance technology, which has been used effectively in over 1,000 patients in various clinical settings including hemodynamic monitoring, heart failure, perioperative care, hemodialysis and stress testing.
Laura Rector, general manager at Cheetah Medical, said: “We believe that with Reliant, healthcare professionals see a device that can deliver a new standard of care.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.